Unity Biotechnology, Inc. Restricted Cash
Unity Biotechnology, Inc. had Restricted Cash of $896.00 thousand as of 2025-03-31, per its 10-Q filed 2025-04-22.
Financial Statements › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCash · last filed 2025-04-22
- 2025-03-31: Restricted Cash $896.00K.
- 2024-09-30: Restricted Cash $896.00K.
- 2024-06-30: Restricted Cash $896.00K.
- 2024-03-31: Restricted Cash $896.00K.
| Period end | Restricted Cash |
|---|---|
| 2025-03-31 | $896.00K 10-Q · filed 2025-04-22 |
| 2024-09-30 | $896.00K 10-Q · filed 2024-11-04 |
| 2024-06-30 | $896.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $896.00K 10-Q · filed 2025-04-22 |
| 2023-09-30 | $896.00K 10-Q · filed 2024-11-04 |
| 2023-06-30 | $896.00K 10-Q · filed 2024-08-06 |
| 2023-03-31 | $896.00K 10-Q · filed 2024-05-14 |
| 2022-09-30 | $1.45M 10-K · filed 2024-04-15 |
| 2022-06-30 | $1.45M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $1.45M 10-Q · filed 2023-05-09 |
| 2021-09-30 | $1.45M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $1.45M 10-Q · filed 2022-08-12 |
| 2021-03-31 | $1.45M 10-Q · filed 2022-05-10 |